方案
99.9%
表单
foil
制造商/商品名称
Goodfellow 508-169-98
电阻率
7.1 μΩ-cm, 0°C
长度 × 宽度 × 厚度
50 mm × 2.0 mm × 2.0 mm
沸点
3900 °C (lit.)
mp
2310 °C (lit.)
密度
12.45 g/cm3 (lit.)
SMILES字符串
[Ru]
InChI
1S/Ru
InChI key
KJTLSVCANCCWHF-UHFFFAOYSA-N
正在寻找类似产品? 访问 产品对比指南
一般描述
For updated SDS information please visit www.goodfellow.com.
法律信息
Product of Goodfellow
储存分类代码
13 - Non Combustible Solids
WGK
nwg
闪点(°F)
Not applicable
闪点(°C)
Not applicable
法规信息
新产品
此项目有
Prashant Kumar et al.
Chemical Society reviews, 43(2), 707-733 (2013-11-07)
Half-sandwich arene ruthenium complexes exhibit versatile chemistry, serve as excellent precursors and find potential applications in many organic transformations. This review mainly focuses on the chemistry of piano-stool ruthenium complexes with special emphasis on the achiral or chiral-at-ruthenium center. Also
Gregory S Smith et al.
Dalton transactions (Cambridge, England : 2003), 40(41), 10793-10800 (2011-08-23)
The introduction of multifunctionalities for tumour targeting is becoming a popular strategy toward the development of new therapeutic agents. In particular, the multifaceted potential of ruthenium(II)-arene complexes show great promise as chemotherapeutics. An ever-increasing number of papers dealing with the
Nicole L Fry et al.
Accounts of chemical research, 44(4), 289-298 (2011-03-03)
Nitric oxide (NO) can induce apoptosis (programmed cell death) at micromolar or higher doses. Although cell death via NO-induced apoptosis has been studied quite extensively, the targeted delivery of such doses of NO to infected or malignant tissues has not
E Tfouni et al.
Current medicinal chemistry, 17(31), 3643-3657 (2010-09-18)
The discovery of the involvement of nitric oxide (NO) in several physiological and pathophysiological processes launched a spectacular increase in studies in areas such as chemistry, biochemistry, and pharmacology. As a consequence, the development of NO donors or scavengers for
Aviva Levina et al.
Metallomics : integrated biometal science, 1(6), 458-470 (2009-11-01)
Interest in Ru anticancer drugs has been growing rapidly since NAMI-A ((ImH(+))[Ru(III)Cl(4)(Im)(S-dmso)], where Im = imidazole and S-dmso = S-bound dimethylsulfoxide) or KP1019 ((IndH(+))[Ru(III)Cl(4)(Ind)(2)], where Ind = indazole) have successfully completed phase I clinical trials and an array of other
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持